{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,4]],"date-time":"2026-04-04T04:27:17Z","timestamp":1775276837405,"version":"3.50.1"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2015,6,24]],"date-time":"2015-06-24T00:00:00Z","timestamp":1435104000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"name":"German Federal Ministry of Education and Research","award":["BMBF-Grant-01ZP0505"],"award-info":[{"award-number":["BMBF-Grant-01ZP0505"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Breast Cancer Res Treat"],"published-print":{"date-parts":[[2015,7]]},"DOI":"10.1007\/s10549-015-3484-2","type":"journal-article","created":{"date-parts":[[2015,6,23]],"date-time":"2015-06-23T12:00:04Z","timestamp":1435060804000},"page":"357-366","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Guidelines are advantageous, though not essential for improved survival among breast cancer patients"],"prefix":"10.1007","volume":"152","author":[{"given":"Regine","family":"Wolters","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J\u00f6rg","family":"Wischhusen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tanja","family":"St\u00fcber","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claire Rachel","family":"Weiss","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mathias","family":"Krockberger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Catharina","family":"Bartmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria","family":"Blettner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wolfgang","family":"Janni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rolf","family":"Kreienberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lukas","family":"Schwentner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Igor","family":"Novopashenny","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manfred","family":"Wischnewsky","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Achim","family":"W\u00f6ckel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joachim","family":"Diessner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2015,6,24]]},"reference":[{"issue":"5","key":"3484_CR1","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1007\/s00103-006-1258-z","volume":"49","author":"J Haberland","year":"2006","unstructured":"Haberland J, Bertz J, Gorsch B, Dolle R, Kurth BM (2006) Future cancer incidents in Germany. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz 49(5):459\u2013467. doi: 10.1007\/s00103-006-1258-z","journal-title":"Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz"},{"key":"3484_CR2","unstructured":"Giersiepen (2005) Gesundheitsberichterstattung des Bundes. Brustkrebs (25)"},{"key":"3484_CR3","unstructured":"Deutschland SB http:\/\/www.destatis.de\/jetspeed\/portal\/search\/results.psml"},{"issue":"17","key":"3484_CR4","doi-asserted-by":"crossref","first-page":"1784","DOI":"10.1056\/NEJMoa050518","volume":"353","author":"DA Berry","year":"2005","unstructured":"Berry DA, Cronin KA, Plevritis SK, Fryback DG, Clarke L, Zelen M, Mandelblatt JS, Yakovlev AY, Habbema JD, Feuer EJ (2005) Effect of screening and adjuvant therapy on mortality from breast cancer. New Engl J Med 353(17):1784\u20131792. doi: 10.1056\/NEJMoa050518","journal-title":"New Engl J Med"},{"issue":"13","key":"3484_CR5","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1056\/NEJMoa1000727","volume":"363","author":"M Kalager","year":"2010","unstructured":"Kalager M, Zelen M, Langmark F, Adami HO (2010) Effect of screening mammography on breast-cancer mortality in Norway. New Engl J Med 363(13):1203\u20131210. doi: 10.1056\/NEJMoa1000727","journal-title":"New Engl J Med"},{"issue":"7182","key":"3484_CR6","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1136\/bmj.318.7182.527","volume":"318","author":"SH Woolf","year":"1999","unstructured":"Woolf SH, Grol R, Hutchinson A, Eccles M, Grimshaw J (1999) Clinical guidelines: potential benefits, limitations, and harms of clinical guidelines. BMJ 318(7182):527\u2013530","journal-title":"BMJ"},{"issue":"2","key":"3484_CR7","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.breast.2009.12.006","volume":"19","author":"A Wockel","year":"2010","unstructured":"Wockel A, Kurzeder C, Geyer V, Novasphenny I, Wolters R, Wischnewsky M, Kreienberg R, Varga D (2010) Effects of guideline adherence in primary breast cancer\u2013a 5-year multi-center cohort study of 3,976 patients. Breast 19(2):120\u2013127. doi: 10.1016\/j.breast.2009.12.006","journal-title":"Breast"},{"issue":"1","key":"3484_CR8","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ejca.2011.06.020","volume":"48","author":"R Wolters","year":"2012","unstructured":"Wolters R, Regierer AC, Schwentner L, Geyer V, Possinger K, Kreienberg R, Wischnewsky MB, Wockel A (2012) A comparison of international breast cancer guidelines\u2014do the national guidelines differ in treatment recommendations? Eur J Cancer 48(1):1\u201311. doi: 10.1016\/j.ejca.2011.06.020","journal-title":"Eur J Cancer"},{"key":"3484_CR9","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1186\/1471-2407-13-487","volume":"13","author":"L Schwentner","year":"2013","unstructured":"Schwentner L, Wockel A, Konig J, Janni W, Ebner F, Blettner M, Kreienberg R, Van Ewijk R (2013) Adherence to treatment guidelines and survival in triple-negative breast cancer: a retrospective multi-center cohort study with 9,156 patients. BMC Cancer 13:487. doi: 10.1186\/1471-2407-13-487","journal-title":"BMC Cancer"},{"issue":"3","key":"3484_CR10","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1093\/annonc\/mdt584","volume":"25","author":"A Wockel","year":"2014","unstructured":"Wockel A, Wolters R, Wiegel T, Novopashenny I, Janni W, Kreienberg R, Wischnewsky M, Schwentner L (2014) The impact of adjuvant radiotherapy on the survival of primary breast cancer patients: a retrospective multicenter cohort study of 8935 subjects. Annal Oncol 25(3):628\u2013632. doi: 10.1093\/annonc\/mdt584","journal-title":"Annal Oncol"},{"key":"3484_CR11","volume-title":"Interdisciplinary S3 guideline for diagnosis and therapy of breast cancer in women","author":"R Kreienberg","year":"2008","unstructured":"Kreienberg R, Albert U, Bartsch HH, Beckmann MW, Berg D, Bick A, du Bois A, Dunst J, Engel J, Ernst B, Geraedts M, Henscher U, H\u00f6lzel D, K\u00f6nig K, Kreipe H, K\u00fchn T, Lebeau A, Leinung S, Link H, L\u00fcck HJ, Maiwald A, Maiwald G, Marschner N, Marx M, von Minckwitz G, Possinger K, Reiter A, Sauerbrei W, Schlake W, Schmutzler R, Schulte H, Schulz KD, Schulz R, Thomssen C, Untch M, Weis J, Zemmler T (2008) Interdisciplinary S3 guideline for diagnosis and therapy of breast cancer in women. German Cancer Society, Berlin"},{"issue":"3","key":"3484_CR12","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1007\/s00117-013-2581-7","volume":"54","author":"K Bock","year":"2014","unstructured":"Bock K, Heywang-Kobrunner S, Regitz-Jedermann L, Hecht G, Kaab-Sanyal V (2014) Mammography screening in Germany. Current results and future challenges. Der Radiol 54(3):205\u2013210. doi: 10.1007\/s00117-013-2581-7","journal-title":"Der Radiol"},{"issue":"1","key":"3484_CR13","doi-asserted-by":"crossref","first-page":"R10","DOI":"10.1186\/bcr3091","volume":"14","author":"JDL Nederend","year":"2014","unstructured":"Nederend JDL, Voogd AC, Groenewoud JH, Jansen FH, Louwman MW (2014) Trends in incidence and detection of advanced breast cancer at biennial screening mammography in The Netherlands: a population based study. Breast Cancer Res 14(1):R10","journal-title":"Breast Cancer Res"},{"issue":"16","key":"3484_CR14","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1056\/NEJMoa052122","volume":"353","author":"EH Romond","year":"2005","unstructured":"Romond EH, Perez EA, Bryant J, Suman VJ, Geyer CE Jr, Davidson NE, Tan-Chiu E, Martino S, Paik S, Kaufman PA, Swain SM, Pisansky TM, Fehrenbacher L, Kutteh LA, Vogel VG, Visscher DW, Yothers G, Jenkins RB, Brown AM, Dakhil SR, Mamounas EP, Lingle WL, Klein PM, Ingle JN, Wolmark N (2005) Trastuzumab plus adjuvant chemotherapy for operable HER2-positive breast cancer. New Engl J Med 353(16):1673\u20131684. doi: 10.1056\/NEJMoa052122","journal-title":"New Engl J Med"},{"issue":"12","key":"3484_CR15","first-page":"4309","volume":"9","author":"PF Bross","year":"2003","unstructured":"Bross PF, Baird A, Chen G, Jee JM, Lostritto RT, Morse DE, Rosario LA, Williams GM, Yang P, Rahman A, Williams G, Pazdur R (2003) Fulvestrant in postmenopausal women with advanced breast cancer. Clin Cancer Res 9(12):4309\u20134317","journal-title":"Clin Cancer Res"},{"issue":"16","key":"3484_CR16","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.1056\/NEJMoa052306","volume":"353","author":"MJ Piccart-Gebhart","year":"2005","unstructured":"Piccart-Gebhart MJ, Procter M, Leyland-Jones B, Goldhirsch A, Untch M, Smith I, Gianni L, Baselga J, Bell R, Jackisch C, Cameron D, Dowsett M, Barrios CH, Steger G, Huang CS, Andersson M, Inbar M, Lichinitser M, Lang I, Nitz U, Iwata H, Thomssen C, Lohrisch C, Suter TM, Ruschoff J, Suto T, Greatorex V, Ward C, Straehle C, McFadden E, Dolci MS, Gelber RD (2005) Trastuzumab after adjuvant chemotherapy in HER2-positive breast cancer. New Engl J Med 353(16):1659\u20131672. doi: 10.1056\/NEJMoa052306","journal-title":"New Engl J Med"},{"issue":"Suppl 6","key":"3484_CR17","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1634\/theoncologist.7-suppl_6-20","volume":"7","author":"AD Seidman","year":"2002","unstructured":"Seidman AD, O\u2019Shaughnessy J, Misset JL (2002) Single-agent capecitabine: a reference treatment for taxane-pretreated metastatic breast cancer? Oncologist 7(Suppl 6):20\u201328","journal-title":"Oncologist"},{"key":"3484_CR18","doi-asserted-by":"crossref","first-page":"f2510","DOI":"10.1136\/bmj.f2510","volume":"346","author":"M Roland","year":"2013","unstructured":"Roland M, Paddison C (2013) Better management of patients with multimorbidity. BMJ 346:f2510. doi: 10.1136\/bmj.f2510","journal-title":"BMJ"},{"issue":"30","key":"3484_CR19","first-page":"1686","volume":"149","author":"ML Janssen-Heijnen","year":"2005","unstructured":"Janssen-Heijnen ML, Maas HA, Lemmens VE, Houterman S, Louwman WJ, Verheij CD, Coebergh JW (2005) The correlation of age and comorbidity with therapy and survival in cancer patients in North-Brabant and North-Limburg, 1995\u20132001. Ned Tijdschr Geneeskd 149(30):1686\u20131690","journal-title":"Ned Tijdschr Geneeskd"},{"issue":"9","key":"3484_CR20","doi-asserted-by":"crossref","first-page":"2150","DOI":"10.1002\/cncr.11338","volume":"97","author":"A DeMichele","year":"2003","unstructured":"DeMichele A, Putt M, Zhang Y, Glick JH, Norman S (2003) Older age predicts a decline in adjuvant chemotherapy recommendations for patients with breast carcinoma: evidence from a tertiary care cohort of chemotherapy-eligible patients. Cancer 97(9):2150\u20132159. doi: 10.1002\/cncr.11338","journal-title":"Cancer"},{"issue":"18","key":"3484_CR21","doi-asserted-by":"crossref","first-page":"3685","DOI":"10.1200\/JCO.2004.07.018","volume":"22","author":"N Hebert-Croteau","year":"2004","unstructured":"Hebert-Croteau N, Brisson J, Latreille J, Rivard M, Abdelaziz N, Martin G (2004) Compliance with consensus recommendations for systemic therapy is associated with improved survival of women with node-negative breast cancer. J Clin Oncol 22(18):3685\u20133693. doi: 10.1200\/JCO.2004.07.018","journal-title":"J Clin Oncol"},{"issue":"5","key":"3484_CR22","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/0021-9681(87)90171-8","volume":"40","author":"ME Charlson","year":"1987","unstructured":"Charlson ME, Pompei P, Ales KL, MacKenzie CR (1987) A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 40(5):373\u2013383","journal-title":"J Chronic Dis"}],"container-title":["Breast Cancer Research and Treatment"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10549-015-3484-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10549-015-3484-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10549-015-3484-2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,30]],"date-time":"2019-05-30T12:43:15Z","timestamp":1559220195000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10549-015-3484-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,6,24]]},"references-count":22,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2015,7]]}},"alternative-id":["3484"],"URL":"https:\/\/doi.org\/10.1007\/s10549-015-3484-2","relation":{},"ISSN":["0167-6806","1573-7217"],"issn-type":[{"value":"0167-6806","type":"print"},{"value":"1573-7217","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,6,24]]}}}